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ABSTRACT
Objectives Cardiovascular diseases are the second 
leading cause of mortality behind HIV/AIDS in South Africa. 
This study investigates cardiovascular disease mortality 
trends in rural South Africa over 20+ years and the 
associated barriers to accessing care, using verbal autopsy 
data.
Design A mixed- methods approach was used, combining 
descriptive analysis of mortality rates over time, by 
condition, sex and age group, quantitative analysis of 
circumstances of mortality (CoM) indicators and free text 
narratives of the final illness, and qualitative analysis of 
free texts.
Setting This study was done using verbal autopsy data 
from the Health and Socio- Demographic Surveillance 
System site in Agincourt, rural South Africa.
Participants Deaths attributable to cardiovascular 
diseases (acute cardiac disease, stroke, renal failure and 
other unspecified cardiac disease) from 1993 to 2015 
were extracted from verbal autopsy data.
Results Between 1993 and 2015, of 15 305 registered 
deaths over 1 851 449 person- years of follow- up, 1434 
(9.4%) were attributable to cardiovascular disease, 
corresponding to a crude mortality rate of 0.77 per 1000 
person- years. Cardiovascular disease mortality rate 
increased from 0.34 to 1.12 between 1993 and 2015. Stroke 
was the dominant cause of death, responsible for 41.0% 
(588/1434) of all cardiovascular deaths across all years. 
Cardiovascular disease mortality rate was significantly higher 
in women and increased with age. The main delays in access 
to care during the final illness were in seeking and receiving 
care. Qualitative free- text analysis highlighted delays not 
captured in the CoM, principally communication between the 
clinician and patient or family. Half of cases initially sought 
care outside a hospital setting (50.9%, 199/391).
Conclusions The temporal increase in deaths due to 
cardiovascular disease highlights the need for greater 
prevention and management strategies for these conditions, 
particularly for the women. Strategies to improve seeking 
and receiving care during the final illness are needed.
INTRODUCTION
Non- communicable diseases (NCDs) are 
estimated to be responsible for two- thirds 
of global mortality.1 Cardiovascular diseases 
(CVDs) are the most prevalent NCD, both 
globally and in South Africa.2 3 NCDs remain 
vastly undersupported; currently less than 
0.1% of South Africa’s national health budget 
is spent on NCDs.4
Access to care is a vital element of universal 
health coverage and a key challenge for 
South Africa; economic, geographical and 
racial inequalities together create vast dispar-
ities.5–7 The South African government is now 
in its second phase of implementing National 
Health Insurance.8 This second phase has 
come with an emphasis on strengthened and 
community- based primary care: a national 
programme, Re- Engineering Primary Health 
Strengths and limitations of this study
 ► This is the first known investigation combining both 
mortality trends and barriers to access to care for 
people who have died of cardiovascular diseases.
 ► In combining quantitative and qualitative analysis to 
develop a three delays model specific to cardiovas-
cular disease in the Agincourt population, this study 
provides a basis for development and application to 
other settings to deal with care access and quality 
issues in the final stages of chronic illness.
 ► Using two components of verbal autopsy data pro-
vides complimentary information and a basis for 
refining circumstances of mortality indicators, but 
direct comparison is limited by methodological dif-
ferences in data collection.
 ► The non- specificity of verbal autopsy cause of death 
categories, particularly ‘other and unspecified car-
diac diseases,’ reduces the ability of this study to 
analyse trends in specific cardiovascular disease 
conditions.
 ► Other factors influencing equity in access to care, 
such as migratory status and socioeconomic sta-
tus, cannot be included due to lack of available data 
within verbal autopsies.  on S
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Care, was initiated in 2010 with the aim of strengthening 
health promotion and prevention and early detection 
of disease.9 As a response to South Africa’s dual burden 
of HIV/AIDS and NCDs, the National Department of 
Health introduced an integrated chronic disease manage-
ment model in 2011.1
Although other studies have quantitively examined 
gaps in care- access using a continuum or ‘cascade’ of 
care approach,10 11 knowledge of where barriers in access 
to care for CVD occur and the identity of such barriers 
in rural South Africa, as well as who is less likely to seek 
care, is a key gap in the literature. This is a crucial area 
for research, as delays in accessing care are an important 
predictor of patient morbidity and mortality for CVD 
outcomes.12
Due to a lack of civil registration data and death certi-
fication systems in many low- income and middle- income 
countries (LMICs), existing data on trends in CVD deaths 
may vary in reliability.13 There is a civil registration system 
in South Africa, with marked improvements in recent 
years, but evaluations have highlighted persisting quality 
issues that may which influence its reliability and validity 
.14 Verbal autopsy (VA) is a method of ascertaining cause 
of death and the circumstances surrounding that death 
in situations—such as deaths in the community—where 
other methods are not available or reliable. VAs are done 
by trained fieldworkers who ask a standard set of ques-
tions to carers of the deceased. Either physician judge-
ment or computer algorithm is used to assign cause of 
death based on these data,15 which has been shown to be 
reliable and reproducible.16 Since 2012, versions of the 
WHO VA tool have included questions on circumstances 
surrounding deaths.17 There is also a free text section 
where fieldworkers record summaries about the death 
and its circumstances, which may include information 
not captured on the binary responses from the rest of the 
VA tool—including access to care. VA presents a unique 
opportunity to understand social exclusion from access 
to health systems within a population, as well as quan-
tify causes of death. When conducted sequentially in the 
same community, VA enables an understanding of how 
patterns of access to health systems change over time. 
This research presents both substantive findings to this 
end and develops the VA methodological approach.
A three delays model can be used to examine barriers 
in accessing care. This approach categorises delays into 
three phases: seeking, reaching and receiving care (see 
online supplemental figure A1),18 and draws attention to 
the multifactorial nature of access to care.19 It facilitates 
an overview of access to care for a particular context by 
breaking down the care pathway into a series of steps, 
and suggests targets for health planning. Use of the 
three delays model has been used extensively for care 
in obstetric emergencies18 with recent broader applica-
tions, for example to sepsis,20 trauma21 22 and time- critical 
conditions.23 It has not yet been applied to CVDs.
This study aims to contribute to bridging the gap 
in the evidence needed to support prioritising and 
planning services for NCDs, which is especially important 
as South Africa works towards the goal of universal health 
coverage.24 This study is the first known investigation 
combining both mortality trends and barriers to access to 
care for people who have died of CVD.
Using VA data, this study documented trends in CVD 
deaths that can be described as ‘downstream’ deaths; 
cardiac conditions, strokes, and renal disease, rather than 
‘upstream’ CVD risk factors (eg, diabetes or hyperten-
sion). It aimed to understand differences over time, by 
condition, age and sex of those dying in a rural popula-
tion in South Africa. This study also aimed to ascertain 
barriers to and patterns of access to care leading up to 
the death, using a three delays framework and examina-
tion of both CoM and free text components of VA data.23 
By combining quantitative and qualitative findings, this 
study aimed to develop a three delays model specific to 
CVD in the Agincourt population, providing a basis for 
development and application of the three delays model 
to the final stages of chronic illness in other settings.
METHODS
Study design
This study presents a mixed- methods analysis of VA data. 
Quantitative analysis comprised of descriptive analysis of 
CVD mortality rates and a three delays approach to anal-
ysis of circumstances of mortality (CoM) indicators and 
free- text narratives of the final illness. Free text narratives 
were also analysed qualitatively.
Study setting and participants
This study was done in the Agincourt Health and Socio- 
Demographic Surveillance System (HDSS) site, in Mpum-
alanga province, rural North East South Africa. The 
HDSS covers an entire sub- district population of ~117 000 
persons and has been stewarded by the MRC/Wits Rural 
Public Health and Health Transitions Research Unit since 
inception.25 The population has been surveyed at least 
annually since 1992, with VA conducted on every death 
in the study population occurring in each preceding year. 
Previous studies have shown recall to be good up to a year 
after a death.26 At the time of research, VA data from 1993 
to 2015 was available.
Quantitative analysis
Measures
Deidentified VA data were electronically stored and three 
elements extracted:
Cause of death: derived using InterVA-527
InterVA-5 is the most recent probabilistic modelling 
approach developed to assign cause of death, using 
responses to VA interview questions. Detailed explana-
tion of how cause of death is assigned is provided by Byass 
et al.28 Two authors (JNLV and JD) reviewed VA cause of 
death categories to select deaths related to CVDs. Included 
categories were ‘acute cardiac disease’ (corresponding 
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to ischaemic heart diseases), ‘stroke’ (corresponding to 
cerebrovascular diseases), ‘renal failure’ (corresponding 
to acute and chronic renal failure) and ‘other and unspec-
ified cardiac disease’ (corresponding to acute rheumatic 
fever; chronic rheumatic heart diseases; pulmonary heart 
disease and diseases of pulmonary circulation; other forms 
of heart disease; disease of arteries, arterioles and capil-
laries; diseases of veins, lymphatic vessel and lymph nodes 
not elsewhere classified; other and unspecified disorders 
of the circulatory system).29 After discussion among the 
authors, renal failure was included in our analysis as a 
CVD outcome because the main causes of chronic kidney 
disease are CVD risk factors—hypertension and diabetes. 
These exceed other causes, such as chronic glomerulo-
nephritis or HIV.30 Chronic kidney disease is especially 
likely to be related to CVD in older adults in this popu-
lation, where CVD risk factors are highly prevalent and 
under- treated.31 To minimise capturing non- CVD causes, 
cases of renal failure deaths in people aged under 40 
years old were excluded.32 InterVA-5 gives a likelihood of 
a death being due to a given cause; greater than 50% was 
required for case inclusion. Each death appears once in 
the analysis.
CoM indicators
The ten CoM indicators are closed questions (see online 
supplemental figure A1) added to the VA tool in 2012, 
which examine social and health systems determinants of 
death and social exclusion from access to care.17 These 
indicators are based on a framework of proximate (biolog-
ical processes preceding outcomes), intermediate (health 
systems factors), and distal (socioeconomic and cultural 
conditions) determinants of health outcomes.17 An 11th 
indicator was included alongside the ten CoM indica-
tors, which asks whether the deceased was discharged 
while still ill. While not part of the CoM indicators, this is 
thought to be important to include, especially for chronic 
conditions such as CVD, as these patients may experience 
multiple cycles of accessing care. It may suggest poor 
quality of care.
Delays in access to care were examined using the CoM 
indicators, including cases where death occurred between 
2012 and 2015 (the years where CoM indicators were 
available). A person was classed as having experienced a 
delay if they had a positive response to the relevant indi-
cator, with the exception of three (calling for help, travel-
ling to a healthcare facility and using motorised transport 
to reach a facility), where a negative response was used to 
capture experiencing a delay.
Free-text descriptions of the death and its circumstances
The free- text sections of each VA are recorded by a 
trained lay field worker at the time of interview. Based 
on discussions with the respondent, most often the 
primary care- giver, this enables more nuanced details 
about circumstances around the time of death to be 
captured.
Analysis
All deaths recorded within the Agincourt population 
were included in the dataset. Systematic house- to- house 
visiting and detailed inquiry of every household member 
limits the risk of missing deaths. Descriptive data were 
generated using SPSS V.25.33
Mortality trends
CVD deaths for each condition category, 5- year time 
period, sex and 10- year age group are described as age- 
sex- time- standardised mortality rates.
Three delays quantitative analysis
To identify inclusion of cases in the three delays analysis, 
cases where free text and CoM data were not both avail-
able were first excluded. Free texts were examined to 
identify cases which were found dead at the scene or had 
died suddenly, with therefore no opportunity to seek care. 
These cases were also excluded. The remaining cases are 
referred to as those ‘able to seek care.’ Responses to CoM 
questions are described as total cases indicating they had 
experienced at least one delay across any of the CoM indi-
cators, shown as a proportion of total cases able to seek 
care. Total cases for each specific delay are then shown as 
a proportion of cases that had experienced at least one 
delay across any of the CoM indicators.
In addition delays extracted from the free text are anal-
ysed quantitatively, in a similar manner for that done with 
the CoM indicators, using data on the three delay coding 
extracted during the qualitative analysis (see below). The 
free text was also examined to determine the first care- 
seeking act, where this information was available.
Qualitative analysis
The free texts were analysed qualitatively to ascertain 
delays in access to care, using a combination of deductive 
and inductive approaches. A deductive approach enabled 
causes of delays to be extracted using a set of a priori 
codes based on the three delays framework of seeking, 
reaching and receiving care. An iterative process23 
enabled emerging codes to be incorporated until satura-
tion was reached.
Initial coding was conducted by JNLV, with codes 
reviewed by JD and AF. This method has been previously 
applied to the same dataset.23 NVivo V.12 software was 
used for the qualitative analysis.25 34
Construction of a three delays model
Finally, a three delays model, specific to CVD in the Agin-
court population, was developed through aggregating 
delays derived from the CoM and free- text analyses.
Patient and public involvement
We did not directly include public involvement in this 
study. The database, from which this study derives data, 
is used to inform a public engagement programme at 
the Medical Research Council/Wits University Rural 
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A total of 15 305 registered deaths occurred over 1 851 
449 person- years between 1993 and 2015. Of these deaths, 
9% (1434) were attributable to CVDs, corresponding to a 
crude CVD mortality rate of 0.77 per 1000 person- years. 
Standardised mortality rates by sex, age group and time 
period are displayed in table 1.
The CVD mortality rate increased from 0.34 in 1993 
(7.0% of all deaths) to 1.12 in 2015 (15.8% of all deaths). 
Across all time periods, stroke was the dominant cause 
of CVD deaths and suggested a linear increase, respon-
sible for 41.0% (588/1434) of all CVD deaths across all 
years (figure 1). Mortality contributions of acute cardiac 
disease (16.3%, 234/1434) and renal failure (4.8%, 
69/1434) were low across all years, although 2010–2015 
saw an increase in acute cardiac disease deaths.
Over the entire time period, the CVD mortality rate was 
higher in women (female:male mortality rate ratio 1.13, 
95% CI 1.02 to 1.26; figure 1). Mortality was higher in 
women for stroke (female:male 1.36, 95% CI 1.15 to 1.61) 
and other and unspecified cardiac diseases (female:male 
1.37, 95% CI 1.15 to 1.63). Mortality was higher in men 
for acute cardiac disease (female:male 0.52, 95% CI 0.40 
to 0.69), there was no significant difference for renal 
failure (female:male 0.63, 95% CI 0.38 to 1.02). CVD 
mortality rate increased with age (figure 1).
Access to care
Between 2012 and 2015, 495 CVD deaths occurred; of 
these 41 (8.3%) cases did not have both free text and CoM 
information available and were excluded from analyses. 
Table 1 Age- sex- time- standardised mortality rates per 1000 person- years for a total 15 305 deaths over 1 851 449 person- 
years, between 1993 and 2015
Total CVD deaths
Acute cardiac 
disease Stroke Renal failure
Other and unspecified 
cardiac disease
Crude mortality rate 0.77 0.13 0.32 0.04 0.29
Sex
  Female 0.82 0.09 0.36 0.03 0.34
  Male 0.73 0.17 0.27 0.05 0.25
Age group
  0–10 0.02 0.00 0.01 N/A 0.00
  11-20 0.07 0.00 0.04 N/A 0.03
  21–30 0.28 0.04 0.10 N/A 0.14
  31–40 0.67 0.11 0.30 N/A 0.26
  41–50 1.55 0.33 0.49 0.13 0.60
  51–60 4.01 0.77 1.48 0.22 1.54
  61–70 7.18 1.05 2.76 0.44 2.93
  71–80 13.68 1.66 5.99 0.69 5.34
  81+ 28.53 5.40 12.89 1.21 9.03
Time period
  1993–1997 0.41 0.04 0.17 0.02 0.19
  1998–2003 0.52 0.05 0.24 0.02 0.22
  2004–2009 0.83 0.07 0.39 0.03 0.34
  2010–2015 1.10 0.27 0.40 0.06 0.37
Data standardised against Agincourt INDEPTH Core Dataset. 53
CVD, cardiovascular disease.
Figure 1 Trends in CVD mortality 1993–2015. (A) CVD 
mortality rates for each 5- year time period disaggregated by 
condition. (B) Male and female CVD mortality rates over time. 
(C) Mortality rates due to cardiovascular disease for each 10- 
year age group. (D) CVD mortality rates for each 20- year age 
group over time. CVD, Cardiovascular disease.
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63 (13.9% of the 454 with data available) were found 
dead at the scene or suffered a sudden death, leaving 391 
cases who were able to seek care. Of these, analysis of the 
free text showed 330 went on to seek care, 322 reached 
care and 310 received care (figure 2).
The CoM analysis showed 36.8% (151/391) of all cases 
which were able to seek care reported at least one delay. 
82.1% (124/151) of these cases reported experiencing 
at least one delay in seeking care, 11.3% (17/151) in 
reaching care, and 32.5% (49/151) in receiving care. In 
64.5% (252/391) of all cases who were able to seek care, 
the free text captured at least one delay. Of these, 46.0% 
(116/252) experienced at least one delay in seeking care, 
4.4% (11/252) in reaching care and 59.9% (151/252) in 
receiving care (table 2).
When considering all delays, there was no significant 
difference in numbers experiencing any delay between 
sexes using the CoM indicators (88 female vs 63 male 
cases, χ2=2.1, p=0.148) or free text (142 female vs 110 
male cases, χ2=0.03, p=0.856). No significant differences 
were seen in numbers experiencing a delay by age group 
on either CoM or free- text analyses.
Significant difference was seen by condition on CoM, 
with 18.1% acute cardiac diseases (13/72), 48.2% 
(67/139) stroke, 46.9% (15/32) renal failure and 37.8% 
(56/148) of other and unspecified cardiac disease cases 
reporting any delay (χ2=19.1, p<0.001). No equivalent 
significant difference was seen on the free text (see online 
supplemental table A1 for delays shown by sex, age group 
and condition).
Qualitative analysis
Themes identified in each delay category are summarised 
below, with a non- exhaustive selection of quotes which 
have been chosen to illustrate themes. Each quote has 
been given by the field worker recording each case.
Delays in seeking care
Of the cases reporting any delay, almost half reported a 
delay in seeking care. However, specific reasons or expla-
nations were rarely given, and lack of care- seeking was 
commonly expressed through phrases like ‘nothing was 
done’ or a refusal to seek care. Only one of the CoM 
indicators on seeking care—traditional medicine—was 
explicitly mentioned in the free text.
Traditional medicine was often sought either before or 
after having sought ‘western’ care. Care was sought from 
a traditional healer following perceived failure of treat-
ment given at a ‘western’ facility and vice versa.
The doctors didn’t say what was wrong. Treatment 
was given but nothing changed… He was taken to 
the private doctor. The doctor didn’t say what was 
wrong… He was taken to the traditional healer.
He went to traditional healer who gave him tradition-
al medicine… Nothing changed. He then went to pri-
vate doctor.
Refusal to seek care was common among cases who did 
not travel to a facility. However, refusal appeared to be 
targeted towards hospitals rather than clinics.
She was taken to the clinic… Treatment was given but 
nothing [changed]. After few days, she was worse. 
She refused to go to the hospital, she died at home.
Delays in reaching care
Reaching care was very rarely discussed in the free text. 
Two explicit delays were mentioned, which related to 
ambulances and dying on the way to healthcare. Other 
cases indicated a delay occurred—such as in cases where 
the intention to seek care had been made—but further 
detail was not provided.
In cases where reaching care was discussed, this mostly 
centred around ambulance transport. Cases which 
mentioned calling directly for an ambulance themselves 
from home frequently experienced delays.
An ambulance was called… It was late and when they 
arrive, they said that she is dead.
In several cases, there were suggestions of an intention 
to seek care but which were unfulfilled. While the free 
text did not provide further insight into the reasons for 
this delay, this suggests there may be additional delays 
following an intention to seek care which were not 
captured in the free text.
Figure 2 Flow diagram showing access to care of all people 
who had CVD deaths between 2012 and 2015, analysed 
using the free text. Notes: number of cases at each stage of 
the care pathway are shown as a proportion of total cases 
which reached the previous step (shown in bold). CoM, 
circumstances of mortality; CVD, cardiovascular disease.
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Table 2 Delays in seeking, reaching and receiving care, as reported in CoM and free texts
Delay
Cases reporting each delay Cases reporting any delay
n %* n %†
CoM
Any delay 151 38.6
Seeking Any delay in seeking care 124 82.1
Costs of care and treatment prohibited other 
household payments
113 74.8
Traditional medicine was used 25 16.7
Telephone or cell phone was not used to call for 
help
16 10.6
Doubts about whether medical care was needed 9 6.0
Reaching Any delay in reaching care 17 11.3
Did not travel to a facility (no reason given) 16 10.6
Did not use motorised transport 16 10.6
Took 2 hours or more to get to the nearest facility 1 0.7
Receiving Any delay in receiving care 49 32.5
Discharged while still ill 40 26.5
Problems with way treated at facility 7 4.6
Problems getting medications or diagnostic tests at 
facility
5 3.3
Problems during admission to the facility 2 1.3
Free text
Any delay 252 64.5
Seeking Any delay in seeking care 116 46.0
At least one delay during seeking care‡ 100 39.7
Traditional medicine was used 18 7.1
Reaching Any delay in reaching care 11 4.4
Death during travel 8 3.2
Ambulance delay 3 1.2
Receiving Any delay in receiving care 151 59.9
Communication 97 38.5
Discharged still ill 35 13.9
Died on arrival/before being treated 13 5.2
Family/self- forced discharge 7 2.8
Problems with treatment 6 2.4
Interhospital referral 5 2.0
No diagnosis given 2 0.8
Delays add up to >100% of cases as individuals could have experienced more than one delay within each delay category
*Denominator=who reported any delay (CoM: n=151, free text: n=252).
†Denominator=cases able to seek care (n=391).
‡The free- text categorisation of ‘at least one delay during seeking care’ combines cases who never sought care (corresponding to the 61 
cases in figure 2) with those who refused to seek care or initially did not seek care but later did, and those who initially sought care and 
later refused in subsequent cycles of accessing care.
CoM, circumstances of mortality.
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She collapsed at the gate… She died after an hour 
before they can take her to healthcare.
Delays in receiving care
Delays in receiving care were reported in the free texts 
of most cases. This tended to focus on issues of commu-
nication between the clinician and patient or family, and 
being discharged while still ill.
A repeated and persistent theme on receiving care was 
that the patient, family or caregiver were not told by the 
clinician what the problem was.
At hospital he was admitted, oxygen, waterdrips and 
tablets was given but all the symptoms didn’t change 
and the doctors didn’t tell the family what was wrong.
In many cases, the patient was reported to have been 
discharged while still ill, frequently leading to re- entering 
the three delays cycle.
He was discharged at the hospital after six days and 
he was still sick. He was taken to another hospital af-
ter a day and he was admitted again… He was not 
getting better… He was discharged being sick.
Referral between hospitals presented an opportunity 
for delays, such as lack of admission at the second hospital, 
being admitted but reporting that nothing was done, 
and/or being referred back to the first hospital without 
any treatment or diagnostic tests being performed. This 
again highlights the non- linearity of accessing care for 
CVDs, as patients re- entered a process of making deci-
sions, travel and readmission.
While she was at hospital she was taken to another 
hospital… To check her chest. She told them that 
they didn’t do anything at the other hospital. They 
didn’t admit her, she was sent back to the first hospi-
tal the same day.
Other cases indicated a lack of alignment between 
hospitals involved in inter- facility referral, particularly 
when patients were sent to another hospital for an oper-
ation. In several cases, such patients were taken to the 
referred hospital only to not receive the operation they 
had travelled for.
The doctor said she need to be operated [and] re-
ferred her to another hospital for operation, but 
she was not admitted and they said they are fully 
booked… She must wait until they have space.
Many cases referenced elements of patient decision 
making which negatively impacted the receipt of care, 
therefore, contributing to delays in receiving care. A 
key theme in patient decision making was self, or family, 
forced early discharge.
She was admitted and given treatment… The family 
asked doctors to discharge her but not given treat-
ment as they promise to bring her back to hospital… 
She was not taken back to hospital… She died at 
home.
Refusal to be admitted to hospital also emerged as a 
patient- led delay in receiving care.
He was taken to the hospital. He refused to be ad-
mitted… He died at home after a day of consultation 
from the hospital.
First care-seeking act
The first care- seeking acts identified from the free text 
are outlined in table 3. Cases were also categorised by 
hospital, non- hospital and delayed first care- seeking act. 
A total of 391 cases were able to seek care and therefore 
were included in the analysis. There were no significant 
differences in first care- seeking act by sex, age group or 
condition.
Table 3 First care- seeking act, shown as number of cases and proportion of total applicable cases (n=391)
Category First care- seeking act Cases Total cases in category
    n % n %
Hospital Hospital 106 27.1 117 29.9
Ambulance 11 2.8
Non- hospital Public clinics and health centres 117 29.9 199 50.9
Private facility 49 12.5
Traditional medicine 12 3.1
Chemist 5 1.3
Home treatment 16 4.1
Delayed 75 19.2
Base=total applicable cases (n=391).
‘Delayed’ includes cases where initially no care was sought but later was, and those who never sought care. This differs from table 2, where 
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Three delays model
A three delays model for CVD outcomes, developed 
through combining qualitative analysis of the free text 
and the quantitative CoM analysis, is shown in online 
supplemental figure A2.
DISCUSSION
While trends in deaths due to CVD have been the subject 
of previous studies,35 36 this is the first known investigation 
combining both mortality trends and barriers to access 
to care for people who have died of CVD. In this low- 
income rural South African population, we found that 
CVD deaths are increasing over time, with an increase in 
mortality rate from 0.34 to 1.12 between 1993 and 2015. 
Most of these deaths were due to stroke, and women 
overall suffered significantly more CVD deaths than men. 
Women experienced fewer ischaemic heart disease events 
than men, contrasting with knowledge from other settings 
that women are as likely to have these conditions as men. 
However, the findings do fit with evidence from else-
where that importance of CVD in women may be under-
estimated37 and underdiagnosed.38 This difference could 
also be due to differences in care seeking behaviours 
among men and women, although this analysis suggests 
there was no difference in reporting barriers to care in 
the final illness by sex.
To ensure validity of our findings, we used two methods 
to examine access to care for CVD in Agincourt, one 
using the CoM indicators and the other, free text. Care 
access was found to be generally good, with most cases 
seeking, reaching and receiving care. Nevertheless, many 
cases did report experiencing multiple and reinforcing 
delays in seeking and receiving care.
Both the CoM and free text highlighted seeking care 
as a key delay in accessing care. Although only 6% of 
respondents said that the deceased doubted the need 
for medical care when explicitly asked in the CoM, most 
cases did not present to hospital or call an ambulance as 
their first care act, suggesting that the urgent need for 
care was not recognised. Early hospital- based care is a crit-
ical determinant of most successful interventions for CVD 
outcomes;39 that the first health- seeking act for people 
who died of acute cardiac disease was often prehospital 
rather than hospital is therefore troubling. Not seeking 
hospital care in the first instance can also lead to a re- entry 
into the three delays cycle, presenting opportunities for 
the patient to experience further delays. Health literacy 
campaigns around symptom recognition and presenting 
to facilities able to deal with these acute conditions could 
improve not only the current access to care cycle but also 
future iterations, and have worked well in other settings.40 
However, this study highlights multiple supply- side factors 
which also drive barriers to care seeking, which likely 
combine and converge with demand- side issues.
The South African public health system aims to provide 
healthcare that is free at the point of use for all.41 Despite 
this, perceived costs were a major barrier to seeking 
care in most cases who experienced delays. Consistent 
reporting of prohibitive costs in Agincourt has also been 
shown elsewhere.17 This may be due to poor information 
on availability of healthcare, or that non- medical direct 
(eg, transport costs, with longer distances to hospitals) 
and indirect costs (eg, fear of loss of earnings) are driving 
this barrier. Overall cost burdens of care have been shown 
to be low in Agincourt, but costs associated with transport 
and difficulty in obtaining income- related exemptions at 
hospitals limit the efficacy of state- provided protection.42 
Work must be done to further delineate the reasons for 
high reporting of prohibitive costs and institute appro-
priate solutions.
Reaching care appeared to be a fairly minimal delay. 
Although free text analysis highlighted a further delay 
not captured in the CoM indicators, ambulance delay, 
the number of cases reporting this was minimal. Short-
ages of ambulances has been a key challenge in this area, 
but the Department of Health has invested in Emer-
gency Medical Services including increasing ambulance 
numbers.43 44 Nevertheless, given that many patients who 
need this service are not using it due to prior barriers 
at the stage of seeking care, investment in ambulance 
services may need to be accompanied by measures to 
reduce these prior barriers.
Receiving care was a common barrier in both the 
CoM and free text analyses. Free texts highlighted many 
barriers not captured by the CoM; it is likely that the 
free text allows expansion on the barriers experienced 
in receipt of complex facility- based care that are not 
possible to capture in the smaller number of CoM fields 
for this delay, pointing to the complementarity of the two 
methods. Phrases like ‘nothing was done,’ and ‘the doctor 
didn’t say what was wrong’ were ubiquitous. It could be 
that healthcare providers are not communicating effec-
tively, or at all, with the patient and/or caregiver, and 
therefore this is an element of clinician–patient interac-
tion which requires intervention. However, it could also 
be an indication that the clinician was not able to deter-
mine a diagnosis, potentially as a result of health system 
weaknesses (eg, availability of equipment, staff training, 
system capacity). Poor quality of care is now a greater 
barrier to reducing mortality in LMICs than insufficient 
access to care,45 so understanding where these issues are 
is vital.
With either interpretation, these free text phrases 
suggest a wider issue of poor perception of care quality. 
Low expectations of care quality are prevalent in LMIC 
settings, including South Africa, which may reduce 
pressure on systems to deliver quality care.46 Percep-
tions of care quality may also inform future care- seeking 
behaviours, as evidenced here by the frequent use of tradi-
tional healers after visiting a ‘western’ facility and feeling 
nothing changed or nothing was done, or by otherwise 
refusing to seek or delaying care- seeking. Refusal of care 
was common, and more so for hospitals than clinics. It 
could be hypothesised that care received in hospitals is 
perceived as poorer than in clinics; further supported by 
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the number of cases who sought non- hospital care in the 
first instance. Patient experience and perceived quality 
of care can impact utilisation of healthcare services.47 
Changing perceptions of hospitals as places to receive 
care and be treated, rather than places to die, requires 
both improvement in the health system to enable hospi-
tals to provide quality care48 and positive messaging 
to individuals and communities. Negative perceptions 
are particularly important to remedy in chronic condi-
tions, which most CVDs are, where patients should have 
multiple opportunities to seek and receive care and are 
likely to accumulate experience and perceptions of care 
quality. Interpersonal skills, improving drug availability 
and technical care (eg, examination, explanation of treat-
ment) have been identified as priority areas to improve 
perceived quality of care in the adjacent Limpopo prov-
ince;49 aligning with the free text analysis in this study. 
However, evidence on perceptions towards care in South 
Africa is limited and warrants further investigation.
This study explores application of the linear frame-
work of the standard three delays model to CVD 
outcomes. However, several findings have highlighted the 
complexity in access to care for chronic conditions: delays 
in receiving care—such as being discharged while still 
ill—influence future care- seeking behaviours, and many 
cases enter multiple cycles. Delays may therefore multiply 
and reinforce each other over the course of multiple iter-
ations of accessing care, even during the final illness as 
examined here. A linear model is oversimplistic for appli-
cation to chronic conditions, which could be better repre-
sented as a cyclical model. This has been raised previously 
in applying the three delays framework to access to care 
in Burkina Faso and Indonesia.50
Study limitations
The non- specificity of InterVA-5 categories was a key limita-
tion, particularly ‘other and unspecified cardiac diseases.’ 
This reduces the ability to analyse trends in specific CVD 
conditions and means it cannot be determined exactly 
what is driving a large proportion of this CVD burden. 
Renal failure was included due CVD risk factors being 
major causes of chronic kidney disease, especially in older 
adults. While we have aimed to minimise the inclusion 
of non- CVD- related causes of renal failure, we acknowl-
edge this analysis may capture deaths due to other causes. 
Other factors influencing equity, such as migratory status 
and socioeconomic status, cannot be included due to 
lack of available data within VAs. That this study could 
not capture these factors limits the utility of the study for 
health planning from an equity perspective. Delays in 
receiving care may be under- reported: respondents may 
have had more direct experience of issues in seeking and 
reaching care, and so be more likely to report these, and 
people who died outside of facilities are also less likely to 
have experienced issues with quality of care, but this does 
not mean the issues do not exist.17
Comparing proportions of cases experiencing each 
delay as calculated by the CoM versus the free text must be 
given careful consideration given the differing methods of 
data collection, but they do provide complimentary infor-
mation amenable to synthesis. In comparing the CoM 
and free text, this study raises the question of breadth vs 
depth. The CoM is an invaluable tool for gaining a broad 
overview of delays in accessing care and are feasible to 
perform at scale. The free text, while able to pick up 
delays not captured in the CoM, is time- consuming to 
analyse with challenges of scalability. However, it has 
been shown that extracted word frequency counts from 
free texts can be used by machine learning for automated 
classification.51 Insight gained from the free text could 
inform expansion or refinement of the CoM to enable 
a greater level of detail to be captured, particularly for 
assessing delays in receiving care. The CoM is continually 
evolving52 and this analysis provides an empirical basis for 
revisiting them.
Future research
The three delays model developed here presents a basis 
for development and application to other settings to deal 
with access and quality issues in the final stages of chronic 
illness. This study also presents an opportunity to revisit 
and refine the CoM indicators. It also highlights several 
avenues for further research. First, the greater burden of 
CVD death among women requires further investigation 
in order to develop strategies to tackle this inequity. Prom-
inent delays in accessing care also require further exam-
ination, particularly around high reporting of prohibitive 
costs, and on perceptions of care quality.
CONCLUSION
This study is the first known investigation combining both 
mortality trends and barriers to access to care for people 
who have died of cardiovascular. It shows the increase 
in deaths due to CVD between 1993 and 2015 in a rural 
region of South Africa. Given CVD in South Africa is now 
the second greatest cause of mortality after HIV/AIDS 
in South Africa,3 there is a vital need for prevention and 
management strategies for these conditions. As women 
suffer a significantly higher CVD mortality than men, they 
should be a key focus of such strategies.
While care pathways appear to be generally good for 
CVD, this study has highlighted issues around seeking 
care, including that many CVD cases first seek care outside 
a hospital setting during the final illness and receiving 
care. Strategies to improve access to care are therefore 
needed. This study highlights the complexity in accessing 
care for chronic conditions such as CVD; many cases 
enter multiple cycles and may experience multiple and 
reinforcing delays. While a three delays model provides 
a valuable framework, the potential need for a cyclical 
model for examining access to care for chronic condi-
tions should be considered.
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Supplementary Table A1: 
Cases reporting any delay, shown as a proportion of the total cases who were able to seek care   
 Results of the CoM 
analysis 
Results of the free 
text analysis 
Cases reporting any 
delay  
Cases reporting any 
delay  
All cases  38.6% 64.5% (252/391) 
Sex Male 36.6% (63/172) 64.0% (110/172) 
Female 40.2% (88/219) 64.8% (142/219) 
Age Group 0-10 0.0% (0/1) 100.0% (1/1) 
11-20 33.3% (1/3) 33.3% (1/3) 
21-30 41.7% (5/12) 58.3% (7/12) 
31-40 30.0% (6/20) 80.0% (16/20) 
41-50 41.5% (17/41) 58.5% (24/41) 
51-60 43.5% (20/46) 67.4% (31/46) 
61-70 34.2% (25/73) 63.0% (46/73) 
71-80 39.0% (30/77) 64.9% (50/77) 
81+ 39.8% (47/118) 64.4% (76/118) 
CVD Condition Acute cardiac disease 18.1% (13/72) 75.0% (54/72) 
Stroke 48.2% (67/139) 58.3% (81/139) 
Renal failure 46.9% (15/32) 65.6% (21/32) 
Other and unspecified 
cardiac disease 
37.8% (56/148) 64.9% (96/148) 
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